Official Title
Whole-Genome Sequencing Analysis of COVID-19 Positive Patients
Brief Summary
We aim to better understand the mode of action of COVID-19 in the context of its interaction with the host genome through whole-genome sequencing.
Enrolling by invitation
Coronavirus Infection
COVID-19
Eligibility Criteria
Inclusion Criteria:
- Ability and acceptance to provide written informed consent and fluent in English.
- Men or women between 18-100+ years, inclusive.
- Willing to comply with study procedures.
- SARS-CoV-2 positive test result as confirmed by a RT-PCR assay with a sputum or
nasopharyngeal sample (either done prior to or at the screening visit).
Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: N/A
Countries
United States
Locations
Vanda Investigational Site
Cleveland, Ohio, United States
Vanda Pharmaceuticals
NCT Number
Keywords
Covid-19
WGS
Viral load
viral genome
MeSH Terms
COVID-19
Coronavirus Infections